AC
BIOT

Antara Capital’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Antara Capital’s Portfolio BIOT Stock Details BIOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,000
Closed -$297K – 288
2022
Q2 		$297K Sell
30,000
-120,000
-80% -$1.18M 0.01% 170
2022
Q1 		$1.48M Hold
150,000
– – 0.05% 155
2021
Q4 		$1.48M Buy
+150,000
New +$1.47M 0.07% 124

Other funds holding BIOT

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
RA
RiverPark Advisors New York $219M AUM 14.91% 1-Year Est. Return
CM
Cohanzick Management Pleasantville, New York $231K AUM 3.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Antara Capital's BIOT Position: Q3 2022 in Review

Antara Capital sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q3 2022, closing a stake of 30,000 shares — an estimated $297K sold.

Antara Capital first reported a position in BIOT in Q4 2021 and held it in 3 quarters. The position peaked at $1.48M in Q1 2022. 69 funds tracked by Wall St. Rank hold BIOT as of Q3 2022.

  • Antara Capital reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Antara Capital sold 30,000 Biotech Acquisition Company Class A Ordinary Shares shares in Q3 2022, an estimated $297K.
  • Antara Capital first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q4 2021 and held it in 3 quarters.
  • Antara Capital's Biotech Acquisition Company Class A Ordinary Shares position peaked at $1.48M in Q1 2022.
  • 69 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q3 2022.

Based on Antara Capital's 13F filing for Q3 2022, filed 14 Nov 2022.